EQUASENS (EQS.PA) Stock Fundamental Analysis
Europe - EPA:EQS - FR0012882389 - Common Stock
40.35 EUR
-0.2 (-0.49%)
We assign a fundamental rating of 6 out of 10 to EQS. EQS was compared to 11 industry peers in the Health Care Technology industry. EQS scores excellent on profitability, but there are some minor concerns on its financial health. EQS is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year EQS was profitable.
In the past year EQS had a positive cash flow from operations.
In the past 5 years EQS has always been profitable.
EQS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
EQS has a better Return On Assets (9.10%) than 72.73% of its industry peers.
EQS's Return On Equity of 15.65% is amongst the best of the industry. EQS outperforms 81.82% of its industry peers.
EQS has a Return On Invested Capital of 12.02%. This is amongst the best in the industry. EQS outperforms 81.82% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EQS is significantly above the industry average of 9.34%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.1% | ||
| ROE | 15.65% | ||
| ROIC | 12.02% |
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
1.3 Margins
Looking at the Profit Margin, with a value of 16.72%, EQS belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
EQS's Profit Margin has been stable in the last couple of years.
The Operating Margin of EQS (20.18%) is better than 90.91% of its industry peers.
In the last couple of years the Operating Margin of EQS has declined.
The Gross Margin of EQS (68.77%) is worse than 63.64% of its industry peers.
EQS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.18% | ||
| PM (TTM) | 16.72% | ||
| GM | 68.77% |
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
2. Health
2.1 Basic Checks
EQS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
EQS has about the same amout of shares outstanding than it did 1 year ago.
EQS has more shares outstanding than it did 5 years ago.
EQS has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 4.03 indicates that EQS is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 4.03, EQS is doing good in the industry, outperforming 72.73% of the companies in the same industry.
The Debt to FCF ratio of EQS is 1.29, which is an excellent value as it means it would take EQS, only 1.29 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of EQS (1.29) is better than 63.64% of its industry peers.
A Debt/Equity ratio of 0.12 indicates that EQS is not too dependend on debt financing.
The Debt to Equity ratio of EQS (0.12) is better than 63.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | 1.29 | ||
| Altman-Z | 4.03 |
ROIC/WACC1.56
WACC7.72%
2.3 Liquidity
EQS has a Current Ratio of 1.21. This is a normal value and indicates that EQS is financially healthy and should not expect problems in meeting its short term obligations.
EQS's Current ratio of 1.21 is in line compared to the rest of the industry. EQS outperforms 45.45% of its industry peers.
A Quick Ratio of 1.10 indicates that EQS should not have too much problems paying its short term obligations.
EQS has a Quick ratio (1.10) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.1 |
3. Growth
3.1 Past
EQS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -23.02%.
EQS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.12% yearly.
Looking at the last year, EQS shows a decrease in Revenue. The Revenue has decreased by -1.37% in the last year.
The Revenue has been growing slightly by 6.45% on average over the past years.
EPS 1Y (TTM)-23.02%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%-24.02%
Revenue 1Y (TTM)-1.37%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%1.49%
3.2 Future
EQS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.63% yearly.
The Revenue is expected to grow by 7.74% on average over the next years.
EPS Next Y18.72%
EPS Next 2Y19.01%
EPS Next 3Y18.63%
EPS Next 5YN/A
Revenue Next Year9.72%
Revenue Next 2Y9.5%
Revenue Next 3Y5.96%
Revenue Next 5Y7.74%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
EQS is valuated correctly with a Price/Earnings ratio of 16.88.
Based on the Price/Earnings ratio, EQS is valued a bit cheaper than 63.64% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.86. EQS is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 14.82, the valuation of EQS can be described as correct.
Based on the Price/Forward Earnings ratio, EQS is valued cheaper than 81.82% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of EQS to the average of the S&P500 Index (23.32), we can say EQS is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.88 | ||
| Fwd PE | 14.82 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, EQS is valued a bit cheaper than 63.64% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, EQS is valued a bit cheaper than 72.73% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.05 | ||
| EV/EBITDA | 9.98 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EQS has a very decent profitability rating, which may justify a higher PE ratio.
EQS's earnings are expected to grow with 18.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.9
PEG (5Y)3.3
EPS Next 2Y19.01%
EPS Next 3Y18.63%
5. Dividend
5.1 Amount
EQS has a Yearly Dividend Yield of 3.13%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.41, EQS pays a bit more dividend than its industry peers.
EQS's Dividend Yield is a higher than the S&P500 average which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.13% |
5.2 History
On average, the dividend of EQS grows each year by 8.00%, which is quite nice.
Dividend Growth(5Y)8%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
51.86% of the earnings are spent on dividend by EQS. This is a bit on the high side, but may be sustainable.
The dividend of EQS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP51.86%
EPS Next 2Y19.01%
EPS Next 3Y18.63%
EPA:EQS (10/6/2025, 5:15:03 PM)
40.35
-0.2 (-0.49%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners11.62%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap612.11M
Analysts80
Price Target50.49 (25.13%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.13% |
Yearly Dividend1.25
Dividend Growth(5Y)8%
DP51.86%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-13.16%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-6.75%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.88 | ||
| Fwd PE | 14.82 | ||
| P/S | 2.82 | ||
| P/FCF | 17.05 | ||
| P/OCF | 12.87 | ||
| P/B | 2.64 | ||
| P/tB | 7.5 | ||
| EV/EBITDA | 9.98 |
EPS(TTM)2.39
EY5.92%
EPS(NY)2.72
Fwd EY6.75%
FCF(TTM)2.37
FCFY5.87%
OCF(TTM)3.13
OCFY7.77%
SpS14.29
BVpS15.26
TBVpS5.38
PEG (NY)0.9
PEG (5Y)3.3
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.1% | ||
| ROE | 15.65% | ||
| ROCE | 14.76% | ||
| ROIC | 12.02% | ||
| ROICexc | 14.31% | ||
| ROICexgc | 35.95% | ||
| OM | 20.18% | ||
| PM (TTM) | 16.72% | ||
| GM | 68.77% | ||
| FCFM | 16.57% |
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
ROICexc(3y)19.36%
ROICexc(5y)21.38%
ROICexgc(3y)50.59%
ROICexgc(5y)62.81%
ROCE(3y)18.64%
ROCE(5y)19.75%
ROICexcg growth 3Y-25.09%
ROICexcg growth 5Y-9.54%
ROICexc growth 3Y-15.77%
ROICexc growth 5Y-10.18%
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
F-Score5
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | 1.29 | ||
| Debt/EBITDA | 0.48 | ||
| Cap/Depr | 79.39% | ||
| Cap/Sales | 5.37% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.41% | ||
| Profit Quality | 99.11% | ||
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.1 | ||
| Altman-Z | 4.03 |
F-Score5
WACC7.72%
ROIC/WACC1.56
Cap/Depr(3y)96.13%
Cap/Depr(5y)118.08%
Cap/Sales(3y)6.18%
Cap/Sales(5y)7.08%
Profit Quality(3y)94.47%
Profit Quality(5y)93.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-23.02%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%-24.02%
EPS Next Y18.72%
EPS Next 2Y19.01%
EPS Next 3Y18.63%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.37%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%1.49%
Revenue Next Year9.72%
Revenue Next 2Y9.5%
Revenue Next 3Y5.96%
Revenue Next 5Y7.74%
EBIT growth 1Y-20.84%
EBIT growth 3Y-4.55%
EBIT growth 5Y1.4%
EBIT Next Year59.12%
EBIT Next 3Y27.46%
EBIT Next 5YN/A
FCF growth 1Y-8.64%
FCF growth 3Y-1.08%
FCF growth 5Y8.7%
OCF growth 1Y-17.61%
OCF growth 3Y0.02%
OCF growth 5Y3.18%